Palomino Laboratories (PALX) Cash from Operations (2023 - 2025)
Palomino Laboratories' (PALX) quarterly Cash from Operations came in at 343500.0 in Q3 2025, down 1189.47% year-on-year from 31529.0 in Q3 2024, and down 582.29% quarter-over-quarter from 50345.0 in Q2 2025.
Palomino Laboratories (PALX) Cash from Operations (2023 - 2025) Analysis & Trends
Palomino Laboratories has disclosed Cash from Operations across 3 years of filings, most recently posting 343500.0 for Q3 2025.
- Cash from Operations for Q3 2025 came in at 343500.0, down 1189.47% year-over-year; the trailing twelve-month figure through Sep 2025 was 558260.0 (changed N/A YoY), and the FY2024 annual result was 166637.0, down 109.93% from the prior year.
- Cash from Operations came in at 343500.0 for Q3 2025 at Palomino Laboratories, down from 50345.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 31529.0 in Q3 2024 to a low of 343500.0 in Q3 2025.
- The 3-year median for Cash from Operations is 53555.5 (2023), against an average of 97249.5.
- Across the five-year window, Cash from Operations plunged 195.01% in 2024 and slumped 1189.47% in 2025, its largest moves.
- Palomino Laboratories' Cash from Operations stood at 56766.0 in 2023, then slumped by 195.01% to 167467.0 in 2024, then slumped by 105.12% to 343500.0 in 2025.
- The last three Cash from Operations figures came in at 343500.0 (Q3 2025), 50345.0 (Q2 2025), and 3052.0 (Q1 2025), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -343,500.00 |
| Sep 30, 2025 | -343,500.00 |
| Jun 30, 2025 | -50,345.00 |
| Jun 30, 2025 | -50,345.00 |
| Mar 31, 2025 | 3,052.00 |
| Mar 31, 2025 | 3,052.00 |
| Dec 31, 2024 | -167,467.00 |
| Dec 31, 2024 | -167,467.00 |
| Sep 30, 2024 | 31,529.00 |
| Sep 30, 2024 | 31,529.00 |
| Dec 31, 2023 | -56,766.00 |
| Dec 31, 2023 | -56,766.00 |